The G-BA Innovation Committee recommends transfer to standard care for two projects in Germany

29

Jul 2022

On June 24, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for two completed projects. The projects relate to preventing delirium, postoperative cognitive dysfunction, and back pain therapy using e-health.

A short overview of the projects is provided below:

  • "PAWEL – Patient safety, cost-effectiveness, and quality of life - reduction of the risk of delirium and postoperative cognitive dysfunction (POCD) after elective surgery in elderly" project offered a diverse approach consisting of a training concept for those treating people in medical practices and hospitals, orientation aids for patients as well as preventive measures and care management for postoperative delirium. With this approach, the incidence rate could be reduced directly after a planned operation, and the decline in mental functions reduced in the medium term;
  • Within the project "Rise-uP – Innovative back pain therapy using e-health for our patients" patients with non-specific back pain received immediate care from general practitioners and specialists based on the previously determined individual risk of the pain becoming chronic. Also, a specific health app was offered that included disease information and exercise instructions to improve both mental and physical health. As a result, the back pain in patients in the project group had decreased significantly more after 12 months than in the control group.

Innovation Fund is a vital instrument to propose and test a novel model of care (including the ones in the form of selective contracts). If the model proves valuable, it can be a subject for further dissemination in the country.

The detailed results of the projects are now being forwarded to the relevant organizations and institutions in the healthcare sector. In this regard, the respective stakeholders are requested to review the results and to consider them within their area of responsibility as far as possible.

The full details in German can be found here, here (decision for PAWEL project), and here (decision for Rise-uP project).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

12

Aug 2022

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on using new and existing health technologies, likely to significantly impact healthcare. In July 2022, SHTG published three reports (KardiaMobile for detecting atrial fibrillation, complex endovascular aneurysm repair, and Togetherall platform). Currently, the SHTG is working on assessments of technologies in the field of cancer, radiotherapy, musculoskeletal diseases, transplantation, and other topics.

Read more

10

Aug 2022

In July 2022, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (transcatheter tricuspid valve annuloplasty for tricuspid regurgitation, and transcatheter tricuspid valve leaflet repair for tricuspid regurgitation), one new Diagnostic Guidance (PLGF-based testing to help diagnose suspected preterm pre-eclampsia), and four new Medtech Innovation Briefings (ProciseDx point-of-care platform for IBD, RespiraSense for continuously monitoring respiratory rate, Lenus COPD Support Service, and cyanoacrylate glue for hernia mesh fixation). Also, five clinical guidelines were updated.

Read more

09

Aug 2022

In May-July 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers.

Read more

08

Aug 2022

In July 2022, the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) published on its website five Digi-HTAs in the fields of eHealth and in-vitro diagnostics.

Read more

03

Aug 2022

On June 27, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for healthcare research projects (seven topics) and clinical guidelines (four topics).

Read more